Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
9%(1 trials)

Phase Distribution

Ph phase_1
2
14%
Ph phase_2
2
14%
Ph not_applicable
1
7%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(11)
Other(3)

Detailed Status

Completed11
unknown3

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (40.0%)
Phase 22 (40.0%)
N/A1 (20.0%)

Trials by Status

unknown321%
completed1179%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT00899652

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Completed
NCT01353300

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Completed
NCT00003863

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Completed
NCT00003648

Genetic Study of Patients and Families With a History of Colorectal Cancer

Completed
NCT01500499

Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia

Completed
NCT01290107

Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia

Completed
NCT00546377Phase 1

Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer

Completed
NCT00006342

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Completed
NCT01062438

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

Completed
NCT00621452Phase 1

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

Completed
NCT00601406Not Applicable

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Unknown
NCT00893477Phase 2

GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Unknown
NCT00896519Phase 2

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

Unknown
NCT00430053

Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma

Completed

All 14 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
14